drugset / Trial / NCT03845348

To Evaluate the Efficacy and Safety of Shampoo TD03 and TD07 in Scalp Diseases

NCT03845348

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Scalp Conditions are common chronic skin inflamations with the occurence rate of 1 - 5 % among the population. TD03 shampoo and TD07 shampoo are widely used to avoid hair loss with successful rate reaching nearly 95%. This trial is going to evaluate the efficacy of getting rid of dandruff as well as the safety of the investigational products in comparison to a reference (ketoconazole 2%) during a 4-week treatment period.

Timeline

Start
2019-05-22
Primary completion
2022-12
Completion
2023-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketoconazole Small molecule 2 % Topical

Indications